The CD-PRO is a self-administered instrument developed in accordance with FDA Guidelines for Content Validity and Instrument Performance. It is intended for use in clinical trials evaluating treatment efficacy in adult patients (≥18 years of age) with moderate to severe Crohn’s disease (CD) treated in an outpatient setting.

The CD-PRO is conceptually designed as a collection of separate and distinct modules that assess the signs, symptoms, and impacts of CD:

  • Signs and Symptoms
  • Systemic Symptoms
  • Coping Strategies
  • Daily Life Impact
  • Emotional Impact

Continue scrolling to find out more about: